1. Home
  2. Analysis
  3. Pregabalin
  4. Walking-disability

Pregabalin and Walking disability - a phase IV clinical study of FDA data

Summary:

Walking disability is reported as a side effect among people who take Pregabalin (pregabalin), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Ocrevus, and have Primary progressive multiple sclerosis.

The phase IV clinical study analyzes which people have Walking disability when taking Pregabalin. It is created by eHealthMe based on reports of 73,056 people who have side effects when taking Pregabalin from the FDA, and is updated regularly.

What is Pregabalin?

Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,070 Pregabalin users. Check the latest studies of Pregabalin.

What is Walking disability?

Walking disability is found to be associated with 289 drugs and 814 conditions by eHealthMe. Check the latest studies of Walking disability.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

73,056 people reported to have side effects when taking Pregabalin.
Among them, 46 people (0.06%) have Walking disability.

Could Pregabalin cause Walking disability?

Among these 46 people:

How long have people been on Pregabalin when they have Walking disability? *

  • < 1 month: 83.33 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 16.67 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Walking disability when taking Pregabalin? *

  • female: 77.78 %
  • male: 22.22 %

What is the age of people who have Walking disability when taking Pregabalin? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 4.76 %
  • 40-49: 69.05 %
  • 50-59: 2.38 %
  • 60+: 23.81 %

What are other drugs people take besides Pregabalin? *

  1. Ocrevus: 28 people, 60.87%
  2. Aspirin: 18 people, 39.13%
  3. Metformin: 18 people, 39.13%
  4. Simvastatin: 18 people, 39.13%
  5. Levothyroxine Sodium: 15 people, 32.61%
  6. Amlodipine Besylate: 14 people, 30.43%
  7. Acetylsalicylic Acid: 12 people, 26.09%
  8. Amlodipine: 11 people, 23.91%
  9. Metformin Hydrochloride: 7 people, 15.22%
  10. Pantoprazole: 4 people, 8.70%

What are other side effects people have besides Walking disability? *

  1. High Blood Pressure: 33 people, 71.74%
  2. Fatigue (feeling of tiredness): 32 people, 69.57%
  3. Tremor (trembling or shaking movements in one or more parts of your body): 31 people, 67.39%
  4. Muscle Spasms (muscle contraction): 31 people, 67.39%
  5. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 31 people, 67.39%
  6. Panic Disorder: 30 people, 65.22%
  7. Nasopharyngitis (inflammation of the nasopharynx): 30 people, 65.22%
  8. Dysmenorrhea (painful menstruation): 30 people, 65.22%
  9. Hypoaesthesia (reduced sense of touch or sensation): 30 people, 65.22%
  10. Dysaesthesia (abnormal sensation): 30 people, 65.22%

What are the existing conditions these people have? *

  1. Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 28 people, 60.87%
  2. Dyslipidaemia (abnormal amount of lipids): 4 people, 8.70%
  3. Primary Myelofibrosis (primary disorder of the bone marrow): 3 people, 6.52%
  4. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 3 people, 6.52%
  5. Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 2 people, 4.35%
  6. Type 2 Diabetes: 1 person, 2.17%
  7. Tremor (trembling or shaking movements in one or more parts of your body): 1 person, 2.17%
  8. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 2.17%
  9. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 2.17%
  10. Neuroendocrine Tumor: 1 person, 2.17%

* Approximation only. Some reports may have incomplete information.

Do you take Pregabalin and have Walking disability?

- Check whether Walking disability is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pregabalin:

Walking disability treatments and more:

How severe was Walking disability and when was it recovered:

Expand to all the drugs that have ingredients of pregabalin:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pregabalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Walking disability:

Browse all the conditions that are associated with Walking disability:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on pregabalin (the active ingredients of Pregabalin) and Pregabalin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.